sotalol has been researched along with toxin ii (anemonia sulcata) in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antzelevitch, C; Shimizu, W | 2 |
| Morita, H; Morita, ST; Wu, J; Zipes, DP | 1 |
| Guo, D; Jia, S; Lian, J; Ma, A; Patel, C; Xue, X; Yan, GX; Yang, L; Yuan, Z | 1 |
4 other study(ies) available for sotalol and toxin ii (anemonia sulcata)
| Article | Year |
|---|---|
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Chromans; Cnidarian Venoms; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction System; Heart Rate; Heart Ventricles; Isoproterenol; Long QT Syndrome; Neurotoxins; Potassium Channel Blockers; Propranolol; Sotalol; Sulfonamides; Sympathetic Nervous System; Treatment Outcome | 2000 |
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chromans; Cnidarian Venoms; Dogs; Electrocardiography; Electrophysiology; Heart; Isoproterenol; Long QT Syndrome; Nicorandil; Potassium Channels; Reaction Time; Sotalol; Sulfonamides; Torsades de Pointes | 2000 |
Analysis of action potentials in the canine ventricular septum: no phenotypic expression of M cells.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Cnidarian Venoms; Dogs; Endocardium; Heart Conduction System; Heart Septum; Heart Ventricles; Long QT Syndrome; Models, Animal; Perfusion; Sotalol | 2007 |
Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Clarithromycin; Cnidarian Venoms; Heart Ventricles; Piperazines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Rabbits; Ranolazine; Sodium Channels; Sotalol; Torsades de Pointes | 2011 |